All Stories

  1. Influence of the binding of reduced NAMI-A to human serum albumin on the pharmacokinetics and biological activity
  2. Linking the future of anticancer metal-complexes to the therapy of tumour metastases
  3. Metal-based antitumour drugs in the post-genomic era: what comes next?
  4. Ruthenium compounds in cancer therapy